dichloromethane = 20:1). 1H NMR (300 MHz, Acetone-d6, ppm) δ:
7.34–7.10 (m, 4H), 7.00–6.83 (m, 3H), 3.86 (t, 2H), 1.80–1.66 (m, 2H),
1.49–1.33 (m, 2H), 1.30–1.19 (m, 4H), 0.83 (t, 3H). ESI-MS m/z: 364.15
[M+H]+.
dialysis membrane. After freeze-drying, 8 (0.65 g, 65%) was obtained as
white floccules. 1H NMR (300 MHz, CDCl3, ppm) δ: 4.20 (d, 4H), 3.91–
3.58 (m, 783H), 3.56–3.45 (m, 106H), 3.44–3.24 (m, 61H), 2.44 (t, 2H),
1.21–1.04 (m, 167H).
PEG-b-PPG-b-PEG-Morpholine (9): Compound 8 (105 mg, 8.26 µmol),
compound 6 (5.6 mg, 32.94 µmol), CuSO4•5H2O (8 mg, 0.032 mmol)
and sodium ascorbate (6.54 mg, 0.032 mmol) were placed in a 50 mL
round-bottom flask under an argon atmosphere. Then anhydrous DMF
(10 mL) was injected into the mixture. The reaction was allowed to
proceed at room temperature for 2 d. After the solvent was removed,
the crude product was suspended in water and purified by dialysis using
3500 Da molecular weight cut-off dialysis membrane. After freeze-drying,
9 (63 mg, 60%) was obtained as grey floccules. 1H NMR (300 MHz,
CDCl3, ppm) δ: 7.69 (s, 2H), 3.98–3.57 (m, 709H), 3.56–3.44 (m, 100H),
3.43–3.28 (m, 57H), 2.88–2.65 (br, 8H), 2.41–2.22 (br, 4H), 2.09–1.87
(br, 4H), 1.16-1.05 (m, 166H).
PEG-b-PPG-b-PEG-Triphenylphosphonium (10): Compound 8 (100 mg,
7.87 µmol), compound 7 (6.93 mg, 15.75 µmol), CuSO4•5H2O (4 mg,
0.016 mmol) and sodium ascorbate (3.17 mg, 0.016 mmol) were placed
in a 50 mL round-bottom flask under an argon atmosphere. Then
anhydrous DMF (10 mL) was injected into the mixture. The reaction
was allowed to proceed at room temperature for 2 d. After the solvent
was removed, the crude product was suspended in water and purified
by dialysis using 3500 Da molecular weight cut-off dialysis membrane.
After freeze-drying, 10 (74.4 mg, 69.62%) was obtained as grey floccules.
1H NMR (300 MHz, CDCl3, ppm) δ: 8.08 (s, 2H), 7.92–7.57 (m, 25H),
3.90–3.58 (m, 783H), 3.56–3.46 (m, 127H), 3.44–3.32 (m, 73H), 1.17–
1.07 (m, 202H).
Preparation of Lysosome- or Mitochondria-Targeted Nanoprobe: To
synthesize the lysosome-targeted nanoprobe, compound 9 (20 mg) and
4 (0.25 mg) were dissolved in 1.0 mL of THF, and then swiftly dropped
into water (10 mL) under sonication. THF was then removed by nitrogen
blowing on the solution surface under stirring at room temperature.
After filtering through a 0.22 µm filter, a bright yellow-green aqueous
solution was obtained. The mitochondria-targeted nanoprobe was
prepared as a bright red aqueous solution through the similar procedure
using compound 10 (20 mg) and 5 (0.25 mg) as the precursors.
Cell Culture: Murine RAW 264.7 cell lines were grown as monolayers
in 75 cm2 flasks containing Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 1% penicillin
streptomycin glutamine (GIBCO) at 37 °C in a humidified incubator
of 5% CO2. Cells were carefully harvested and split when they reached
80% confluence to maintain exponential growth.
Cytotoxicity Test: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assays were performed to assess the metabolic
activity of macrophage cells. The cells were seeded in 96-well plates
(Costar, Chicago, IL) at an intensity of 2 × 104 cells mL−1. After 24 h of
incubation, the medium was replaced by the nanoprobe solution at the
concentration of 5, 10, 15, 20, 25, and 30 µg mL−1, and the cells were
then incubated for 24 h. After the designated time intervals, the wells
were washed twice with PBS buffer, and 100 µL MTT solution (0.5 mg
mL−1) was added to each well. After incubation for 3 h at 37 °C, the
MTT medium solution was carefully removed and the formazan crystals
were solubilized with 200 µL of dimethylsulfoxide for 15 min. The
absorbance value was recorded at 490 nm using a microplate reader.
The absorbance of the untreated cells was used as a control with its
absorbance as the reference value for calculating 100% cellular viability.
Cellular Imaging: For determining the subcellular location of the
nanoprobe, live RAW 264.7 macrophage cells cultured in 35 mm glass
bottom culture dishes were incubated with 20 µg mL−1 nanoprobe
(LNP or MNP) for 24 h. Then LysoTracker (1.0 × 10−6 m) or MitoTracker
(1.0 × 10−6 m) was added for another 15 min. Then the cells were washed
by PBS prior to imaging. To investigate multicolor cellular imaging of
different organelles, the experiment can be divided into three groups.
For one group, the macrophage cells were cultured with the LNP/MNP
nanoprobe cocktail (30 µg mL−1) for 24 h prior to imaging. In the second
group, macrophage cells were pretreated with LPS (100 ng mL−1)/
IFN-γ (20 ng mL−1) for 24 h, then treated with LNP/MNP nanoprobe
10-Hexyl-3-vinyl-10H-phenothiazine (3):
2 (4.00 g, 11.02 mmol),
tributyl(vinyl)tin (4.21 g, 13.22 mmol), Pd(PPh3)2Cl2 (0.685 g,
0.97 mmol) and 2, 6-di-tert-butylphenol (95 mg, 0.46 mmol) were placed
in a 50 mL round-bottom flask and the reaction vessel was degassed
and purged with N2. Then 20 mL of anhydrous toluene was injected into
the mixture, which was subjected to three freeze-pump-thaw cycles to
remove O2. The mixture was vigorously stirred at 100 °C for 24 h. After
the organic solvent was distilled out, the crude product was purified by
column chromatography (silica gel, petroleum ether: dichloromethane =
1:1) to give yellow-green oil (1.64 g, 48.1%). 1H NMR (300 MHz, CDCl3,
ppm) δ: 7.22–7.09 (m, 4H), 6.94–6.75 (m, 3H), 6.65–6.52 (m, 1H),
5.61 (d, 1H), 5.13 (d, 1H), 3.83 (t, 2H), 1.86–1.73 (m, 2H), 1.48–1.38
(m, 2H), 1.34–1.25 (m, 4H), 0.88 (t, 3H). ESI-MS m/z: 310.24 [M+H]+.
1,4-Bis((E)-2-(10-hexyl-10H-phenothiazin-3-yl)vinyl)benzene
(4): A Schlenk tube was charged with 3 (200 mg, 0.65 mmol),
1,4-dibromobenzene (76.66 mg, 0.33 mmol), Pd(OAc)2 (8 mg,
35.64 µmol), and P(o-tolyl)3 (36 mg, 117.6 µmol) before it was sealed
with a rubber septum. The Schlenk tube was degassed with three
vacuum-argon cycles to remove air. Then, DMF (3 mL) and triethylamine
(0.8 mL) were added to the Schlenk tube, and the mixture was frozen,
evacuated, and thawed three times to further remove air. The reaction
was then conducted at 100 °C for 2 d. After the organic solvent was
distilled out, the crude product was purified by column chromatography
(silica gel, petroleum ether: dichloromethane = 1:1) to afford yellow-
1
green oil (94.58 mg, 41.4%). H NMR (300 MHz, CDCl3, ppm) δ: 7.45
(s, 4H), 7.32–7.27 (m, 4H), 7.13 (d, 4H), 7.00–6.77 (m, 10H), 3.84 (t,
4H), 1.87–1.75 (m, 4H), 1.47–1.39 (m, 4H), 1.35–1.28 (m, 8H), 0.88 (t,
6H). ESI-MS m/z: 692.36 [M]+.
4,7-Bis((E)-2-(10-hexyl-10H-phenothiazin-3-yl)vinyl)benzo[c][1,2,5]
thiadiazole (5): Compound 5 was synthesized by a similar procedure
with compound 4 using 4, 7-dibromobenzo[c][1,2,5]thiadiazole instead
1
of 1, 4-dibromobenzene as the starting material. Yield: 38.2%. H NMR
(300 MHz, THF-d8, ppm) δ: 8.02 (d, 2H), 7.73 (s, 2H), 7.56 (d, 2H),
7.46–7.40 (m, 4H), 7.15–7.07 (m, 4H), 6.96 (t, 4H), 6.88d (t, 2H),
3.93 (t, 4H), 1.85–1.76 (m, 4H), 1.52–1.42 (m, 4H), 1.34–1.27 (m, 8H),
0.88 (t, 6H). MALDI-TOF, m/z: Calcd, 750.29; Found, 750.53 [M]+.
4-(3-Azidopropyl)morpholine (6): Sodium azide (0.78 g, 12 mmol)
was added to a solution of 4-(3-bromopropyl)morpholine (0.5 g,
2.42 mmol) in anhydrous DMF (20 mL) and the mixture was stirred
at room temperature for 24 h. After the solvent was removed by rotary
evaporation, the mixture was extracted with water and dichloromethane.
The pure product can be obtained without further purification after
removing the solvent of organic layer (0.39 g, 94.66%). 1H NMR
(300 MHz, CDCl3, ppm) δ: 3.70 (t, 4H), 3.34 (t, 2H), 2.51–2.33 (m, 6H),
1.80–1.71 (m, 2H). ESI-MS m/z: 171.03 [M+H]+.
(4-Azidobutyl)triphenylphosphonium Bromide (7): Sodium azide
(153 mg, 2.35 mmol) was added to a solution of (4-bromobutyl)
triphenylphosphonium bromide (0.73 g, 1.53 mmol) in anhydrous DMF
(15 mL) and the mixture was stirred at room temperature for 24 h.
After the solvent was removed by rotary evaporation, dichloromethane
was added to the mixture and the precipitate was removed. The
product was obtained as white crystals after distilling dichloromethane
(0.61 g, 89.97%). 1H NMR (300 MHz, CDCl3, ppm) δ: 7.93–7.59 (m,
15H), 3.89 (t, 2H), 3.42 (t, 2H), 2.10–1.89 (m, 2H), 1.80–1.58 (m, 2H).
ESI-MS m/z: 360.12 [M−Br−]+.
PEG-b-PPG-b-PEG-Alkyne (8): PEG-b-PPG-b-PEG (1 g, 0.079 mmol),
sodium hydride (60% in mineral oil, 38 mg, 0.95 mmol) and 10 mL
anhydrous THF were placed in a 50 mL round-bottom flask and the
mixture kept stirring for 1 h. Then 250 µL 3-bromoprop-1-yne (80% in
toluene) was added and the mixture was stirred at room temperature
for 24 h. After the precipitate was filtered away, the mixture was
concentrated and poured into diethyl ether. The precipitate was collected
and redissolved in water. Finally, the product was purified by dialysis
against distilled water for 2 d using a 5000 Da molecular weight cut-off
©
Adv. Funct. Mater. 2017, 1700493
1700493 (8 of 9)
2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim